期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
苯丙胺类兴奋剂滥用的治疗研究进展 被引量:29
1
作者 江海峰 赵敏 +2 位作者 孙海明 王石斌 Walter Ling 《中国药物依赖性杂志》 CAS CSCD 2008年第4期259-262,共4页
关键词 苯丙胺类兴奋剂 中枢神经系统兴奋剂 苯丙胺类精神兴奋剂 苯丙胺类中枢兴奋剂 甲基苯丙胺 治疗 苯丙胺类物质 精神活性物质
下载PDF
Drug-abusing Offenders with Co-morbid Mental Disorders:Gender Differences in Problem Severity,Treatment Participation,and Recidivism
2
作者 DU Jiang HUANG David +1 位作者 ZHAO Min HSER Yih Ing 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2013年第1期32-39,共8页
Objective This study examined the gender differences in drug‐related problems and predictors of recidivism among a sample of 1444 offenders with co‐morbid drug abuse and mental disorders participating in California... Objective This study examined the gender differences in drug‐related problems and predictors of recidivism among a sample of 1444 offenders with co‐morbid drug abuse and mental disorders participating in California's Proposition 36 Program.Methods Background characteristics and problem severity in multiple key life areas were assessed at intake by using Addiction Severity Index,and drug treatment participation,mental health diagnoses and arrests were based on official records.Results Women demonstrated greater problem severity than men in family relationships,health,psychological health,and sexual and physical abuse history.Men on the other hand had greater criminal history,high rates of attention disorder,and psychotic disorder.More men than women were rearrested during the year after treatment admission.Logistic regression analyses showed that for the combined sample,male,young age,cocaine use(relative to methamphetamine),drug abuse severity,methadone treatment,arrest history and fewer prior treatment history were associated with higher recidivism at 12‐month follow‐up;lower education,cocaine use,and arrest history were related to women's recidivism,while young age,outpatient treatment,and arrest history were predictors of men's recidivism.Conclusion Although the specific type of mental disorder did not seem to be predictive of recidivism,the high rates of mental health disorder and arrest of this population is problematic.Intervention strategies taking into consideration gender‐specific problems and needs can improve outcomes for both. 展开更多
关键词 Drug abuse OFFENDER Mental disorder Gender difference
下载PDF
Cannabis and Psychosis: A Review of the Risk Factors Involved
3
作者 Mohamed Ben Amar 《American Journal of Plant Sciences》 2020年第12期1949-1990,共42页
Abundant literature suggests the hypothesis that cannabis use leads to the onset of psychotic symptoms. However, the nature of the association and the causal link remain controversial. This review aims to identify the... Abundant literature suggests the hypothesis that cannabis use leads to the onset of psychotic symptoms. However, the nature of the association and the causal link remain controversial. This review aims to identify the risk factors involved in the etiopathogenesis of psychosis or psychotic features. Our electronic search found 1653 studies published until March 1<sup><span style="font-family:Verdana;">st</span></sup><span style="font-family:Verdana;"> 2020. Longitudinal studies and literature reviews were selected if they addressed specifically the issues of the cannabis/psychosis relationship and the eventual risk factors involved. Our systematic review identified six potential risk factors involved in the association. They are, in decreasing importance, the dose-response relationship (quantity, frequency and duration of cannabis use), the early age of cannabis consumption, genetic susceptibility, childhood trauma, cigarette smoking and urban environment. In contrast, a significant inverse relationship exists between cannabidiol (CBD) and psychosis: cannabidiol is associated with less psychotic symptoms and manifests antipsychotic properties. Further studies are needed to establish a clear causal relationship between cannabis and psychosis and to identify the qualitative and quantitative contribution of specific risk factors on its onset and sustainability.</span> 展开更多
关键词 CANNABIS Marijuana Hashish PSYCHOSIS SCHIZOPHRENIA Risk Factors
下载PDF
阿片依赖的循证药物治疗:从研究到应用
4
作者 Walter LING 《中国药物依赖性杂志》 CAS CSCD 2009年第4期343-343,共1页
上世纪60年代美沙酮的诞生给阿片成瘾的治疗带来了巨大的变化。目前,已有3种药物被研究证实为有效:美沙酮、纳曲酮和丁丙诺啡。本文将介绍这些药物,讨论它们如何起效,它们之间的相似之处和差异,以及是什么决定了它们在临床应用中的成功... 上世纪60年代美沙酮的诞生给阿片成瘾的治疗带来了巨大的变化。目前,已有3种药物被研究证实为有效:美沙酮、纳曲酮和丁丙诺啡。本文将介绍这些药物,讨论它们如何起效,它们之间的相似之处和差异,以及是什么决定了它们在临床应用中的成功或失败。尽管被证实的安全性和有效性对每一种成功的药物治疗方法都是必要的,但只有这些不足以确保临床上成功的应用。在被患者接受之前,社会的态度和政策有力地影响了某种药物在社会层面上被接受还是拒绝。最终,任何一种阿片依赖药物治疗方法的成功或失败依赖于社会如何看待阿片成瘾、成瘾者,以及必须为他们所做的事情。 展开更多
关键词 循证医学 阿片依赖 药物治疗
下载PDF
Dose,Plasma Level,and Treatment Outcome Among Methadone Patients in Shanghai,China 被引量:1
5
作者 Haifeng Jiang Maureen Hillhouse +7 位作者 Jiang Du Shujun Pan Ang Alfonso Jun Wang Zhirong Zhou Weijun Yuan Walter Ling Min Zhao 《Neuroscience Bulletin》 SCIE CAS CSCD 2016年第6期538-544,共7页
Abstract The purpose of this study was to investigate the blood levels of methadone in participants receiving methadone for the treatment of opioid dependence. After stabilization on methadone for four weeks, blood sa... Abstract The purpose of this study was to investigate the blood levels of methadone in participants receiving methadone for the treatment of opioid dependence. After stabilization on methadone for four weeks, blood samples from 95 participants were collected between treatment weeks 4 and 12, before and after receiving doses of methadone, and its blood levels were measured. A multiple linear regression model was used to examine the associa- tion between methadone blood levels and the outcomes of methadone maintenance treatment (MMT). Outcome dif- ferences between participants who had high (≥2) or low (〈2) peak-to-trough ratios were also compared using an independent sample t-test. The blood level of methadone was not correlated with the clinical outcome of MMT with the moderate range of doses given. However, the retention of patients who had a free peak-to-trough ratio 〉2 was significantly poorer than those whose ratio was 〈2. Thus, monitoring plasma methadone levels is unlikely to be effective for guiding dosing decisions in situations where compliance with MMT is already very high or when themethadone dose is no longer the dominant factor in determining the clinical outcome. However, monitoring plasma methadone levels is still helpful for guiding the dosage for patients with a rapid metabolism. 展开更多
关键词 METHADONE Plasma level TREATMENTOUTCOME METABOLISM
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部